PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 3, 2025Clinical Chemistry0 citationsOpen Access

A-368 Point of Care Testing Expedites Treatments Provided by Community Paramedics

View Full Paper
TBTina BigaouetteTSTraci SchumannAWAmy M. Wockenfus

Key Points

  • Point of care testing expedited therapeutic interventions, allowing quicker decisions for heart failure patients.
  • Approximately 41.2% of test results were outside reference intervals, indicating substantial clinical impact on patient management.
  • Testing utilized i-STAT cartridges, which facilitated on-site laboratory analysis of critical blood parameters.
  • This proactive model may expand to address other chronic health conditions, highlighting its potential for broader application.

Abstract

Abstract Background Community Paramedic (CP) programs use specially trained paramedics to provide healthcare in the community to increase access to care, reduce unnecessary emergency department visits, and improve timeliness of care. Mayo Clinic in Rochester, MN recently launched a CP Program to provide in-home care for patients who require regular intravenous medications, wound care, diuresis for heart failure, medication reconciliation, care plan compliance/education. CP utilizes i-STAT1 CHEM8+ and Lactate (CG4+) testing (Abbott Point of Care, Abbott Park, IL) to make therapy decisions primarily for heart failure patients based on rapid laboratory results. Having results available at the point of care (POC) eliminates delays between testing and treatments, expediting care for the patient. Prior to using i-STAT, CP traveled to the patient’s residence, drew blood tubes, delivered the tubes to Mayo Clinic, waited for test results, returned to the patient’s home, and provided treatment. In this observational study, we assessed the benefit of in-home POC i-STAT1 testing performed by our CP Program to improve patient care and increase efficiency. Methods Patients within a 40-mile radius of Mayo Clinic were eligible to receive CP service. Whole blood venous specimens were collected and tested using the i-STAT1 CHEM8+ metabolic panel cartridge according to manufacturer instructions to measure: ionized calcium, chloride, glucose, hematocrit, total carbon dioxide, blood urea nitrogen, creatinine, potassium, sodium, anion gap while the i-STAT1 CG4+ cartridge measures lactate. The laboratory information system was used to extract laboratory results, and Excel (Microsoft, Redmond, WA) was used to filter data and perform calculations. Results November 2022 through December 2024, CP performed testing with 353 i-STAT cartridges (3862 tests) on 102 unique patients who each had 1-12 separate orders. Patient ages were 25 to 97 years. 41.2% (1590/3862) of the individual results obtained were outside of our reference intervals (23.0% high, 18.0% low), with 10.8% being ionized calcium, 10.2% chloride, 10.3% glucose, 13.0% hematocrit, 7.6% total carbon dioxide, 18.2% blood urea nitrogen, 16.4% creatinine, 6.7% potassium and 6.9% sodium. Additionally, 0.13% of results were critically high (ionized calcium, potassium, and sodium) and 0.10% were critically low (potassium and ionized calcium). Hypokalemic patients were sent to the infusion therapy center for IV potassium. Patients experiencing hyperkalemia were retested and sent to the emergency department (ED). Hyponatremic and hypercalcemic patients were sent to the ED for further treatment. Abnormal (non-critical) results were reviewed by CP personnel to make treatment recommendations or medication adjustments. Conclusion i-STAT1 home testing performed by CP facilitated rapid therapeutic interventions and expedited decision-making. POC testing has increased the group’s efficiency—alleviating the need to transport specimens to the central laboratory and wait on test results before returning to the patient for treatment. Paramedicine emphasizes a proactive and preventative approach to medicine. We anticipate that this model of care and testing will expand to cover other chronic health conditions due to the program’s early success.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bigaouette et al. (2025) studied this question.

synapsesocial.com/papers/68e040e5a99c246f578b2f34https://doi.org/10.1093/clinchem/hvaf086.352
Ask AI
Helpful
Bookmark
Share
View Full Paper